US Stock MarketDetailed Quotes

Organon & Co (OGN)

Watchlist
  • 5.860
  • -0.260-4.25%
Close Apr 8 15:59 ET
  • 5.890
  • +0.030+0.51%
Post 19:13 ET
1.53BMarket Cap8.14P/E (TTM)

Organon & Co (OGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-2.92%6.22B
-5.34%1.51B
1.26%1.6B
-0.81%1.59B
-6.72%1.51B
2.24%6.4B
-0.38%1.59B
4.15%1.58B
-0.06%1.61B
5.46%1.62B
Operating revenue
-2.92%6.22B
-5.34%1.51B
1.26%1.6B
-0.81%1.59B
-6.72%1.51B
2.24%6.4B
-0.38%1.59B
4.15%1.58B
-0.06%1.61B
5.46%1.62B
Cost of revenue
8.00%2.9B
10.06%766M
13.05%745M
7.78%720M
1.05%672M
6.88%2.69B
1.90%696M
7.68%659M
4.38%668M
14.66%665M
Gross profit
-10.82%3.31B
-17.30%741M
-7.15%857M
-6.92%874M
-12.12%841M
-0.88%3.72B
-2.08%896M
1.76%923M
-3.00%939M
-0.10%957M
Operating expense
-6.37%2.09B
-12.67%524M
-6.38%499M
-0.90%548M
-4.97%516M
-7.93%2.23B
-0.50%600M
-21.04%533M
-4.49%553M
-3.72%543M
Selling and administrative expenses
-2.22%1.72B
-7.87%433M
-1.66%415M
3.66%453M
-2.55%420M
-7.03%1.76B
0.21%470M
-21.56%422M
-3.10%437M
-0.92%431M
Research and development costs
-21.96%366M
-30.00%91M
-24.32%84M
-18.10%95M
-14.29%96M
-11.17%469M
-2.99%130M
-18.98%111M
-9.38%116M
-13.18%112M
Operating profit
-17.50%1.23B
-26.69%217M
-8.21%358M
-15.54%326M
-21.50%325M
11.98%1.49B
-5.13%296M
68.10%390M
-0.77%386M
5.08%414M
Net non-operating interest income expense
3.08%-504M
8.33%-121M
-1.59%-128M
0.00%-131M
5.34%-124M
1.33%-520M
-2.33%-132M
5.97%-126M
0.76%-131M
0.76%-131M
Non-operating interest expense
-3.08%504M
-8.33%121M
1.59%128M
0.00%131M
-5.34%124M
-1.33%520M
2.33%132M
-5.97%126M
-0.76%131M
-0.76%131M
Other net income (expense)
-86.79%-297M
-597.14%-244M
122.81%13M
270.00%34M
-112.77%-100M
-25.20%-159M
55.70%-35M
-216.67%-57M
-566.67%-20M
-74.07%-47M
Gain on sale of security
46.15%-14M
86.67%-2M
-183.33%-17M
0.00%1M
166.67%4M
38.10%-26M
11.76%-15M
57.14%-6M
150.00%1M
33.33%-6M
Special income (charges)
-258.93%-402M
-3,750.00%-308M
--0
86.67%-2M
-142.11%-92M
-60.00%-112M
86.21%-8M
---51M
---15M
-216.67%-38M
-Less:Restructuring and merger&acquisition
206.45%95M
-12.50%7M
--0
--2M
273.91%86M
-50.00%31M
-86.21%8M
--0
--0
475.00%23M
-Less:Impairment of capital assets
--301M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
-92.59%6M
--0
----
----
-60.00%6M
912.50%81M
--0
--51M
--15M
87.50%15M
Other non- operating income (expenses)
666.67%119M
650.00%66M
--30M
683.33%35M
-300.00%-12M
-40.00%-21M
-200.00%-12M
----
-500.00%-6M
50.00%-3M
Income before tax
-47.34%425M
-214.73%-148M
17.39%243M
-2.55%229M
-57.20%101M
19.91%807M
24.04%129M
158.75%207M
-7.48%235M
0.43%236M
Income tax
517.54%238M
185.00%57M
154.61%83M
110.00%84M
-60.00%14M
83.71%-57M
104.52%20M
-790.91%-152M
233.33%40M
-39.66%35M
Net income
-78.36%187M
-288.07%-205M
-55.43%160M
-25.64%145M
-56.72%87M
-15.54%864M
-80.04%109M
518.97%359M
-19.42%195M
13.56%201M
Net income continuous Operations
-78.36%187M
-288.07%-205M
-55.43%160M
-25.64%145M
-56.72%87M
-15.54%864M
-80.04%109M
518.97%359M
-19.42%195M
13.56%201M
Minority interest income
Net income attributable to the parent company
-78.36%187M
-288.07%-205M
-55.43%160M
-25.64%145M
-56.72%87M
-15.54%864M
-80.04%109M
518.97%359M
-19.42%195M
13.56%201M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-78.36%187M
-288.07%-205M
-55.43%160M
-25.64%145M
-56.72%87M
-15.54%864M
-80.04%109M
518.97%359M
-19.42%195M
13.56%201M
Basic earnings per share
-78.57%0.72
-288.10%-0.79
-56.12%0.61
-26.32%0.56
-56.41%0.34
-16.21%3.36
-80.37%0.42
504.35%1.39
-20.00%0.76
11.43%0.78
Diluted earnings per share
-78.38%0.72
-288.10%-0.79
-55.80%0.61
-25.33%0.56
-57.69%0.33
-16.54%3.33
-80.28%0.42
500.00%1.38
-21.05%0.75
13.04%0.78
Dividend per share
-69.64%0.34
-92.86%0.02
-92.86%0.02
-92.86%0.02
0.00%0.28
0.00%1.12
0.00%0.28
0.00%0.28
0.00%0.28
0.00%0.28
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -2.92%6.22B-5.34%1.51B1.26%1.6B-0.81%1.59B-6.72%1.51B2.24%6.4B-0.38%1.59B4.15%1.58B-0.06%1.61B5.46%1.62B
Operating revenue -2.92%6.22B-5.34%1.51B1.26%1.6B-0.81%1.59B-6.72%1.51B2.24%6.4B-0.38%1.59B4.15%1.58B-0.06%1.61B5.46%1.62B
Cost of revenue 8.00%2.9B10.06%766M13.05%745M7.78%720M1.05%672M6.88%2.69B1.90%696M7.68%659M4.38%668M14.66%665M
Gross profit -10.82%3.31B-17.30%741M-7.15%857M-6.92%874M-12.12%841M-0.88%3.72B-2.08%896M1.76%923M-3.00%939M-0.10%957M
Operating expense -6.37%2.09B-12.67%524M-6.38%499M-0.90%548M-4.97%516M-7.93%2.23B-0.50%600M-21.04%533M-4.49%553M-3.72%543M
Selling and administrative expenses -2.22%1.72B-7.87%433M-1.66%415M3.66%453M-2.55%420M-7.03%1.76B0.21%470M-21.56%422M-3.10%437M-0.92%431M
Research and development costs -21.96%366M-30.00%91M-24.32%84M-18.10%95M-14.29%96M-11.17%469M-2.99%130M-18.98%111M-9.38%116M-13.18%112M
Operating profit -17.50%1.23B-26.69%217M-8.21%358M-15.54%326M-21.50%325M11.98%1.49B-5.13%296M68.10%390M-0.77%386M5.08%414M
Net non-operating interest income expense 3.08%-504M8.33%-121M-1.59%-128M0.00%-131M5.34%-124M1.33%-520M-2.33%-132M5.97%-126M0.76%-131M0.76%-131M
Non-operating interest expense -3.08%504M-8.33%121M1.59%128M0.00%131M-5.34%124M-1.33%520M2.33%132M-5.97%126M-0.76%131M-0.76%131M
Other net income (expense) -86.79%-297M-597.14%-244M122.81%13M270.00%34M-112.77%-100M-25.20%-159M55.70%-35M-216.67%-57M-566.67%-20M-74.07%-47M
Gain on sale of security 46.15%-14M86.67%-2M-183.33%-17M0.00%1M166.67%4M38.10%-26M11.76%-15M57.14%-6M150.00%1M33.33%-6M
Special income (charges) -258.93%-402M-3,750.00%-308M--086.67%-2M-142.11%-92M-60.00%-112M86.21%-8M---51M---15M-216.67%-38M
-Less:Restructuring and merger&acquisition 206.45%95M-12.50%7M--0--2M273.91%86M-50.00%31M-86.21%8M--0--0475.00%23M
-Less:Impairment of capital assets --301M------------------0----------------
-Less:Other special charges -92.59%6M--0---------60.00%6M912.50%81M--0--51M--15M87.50%15M
Other non- operating income (expenses) 666.67%119M650.00%66M--30M683.33%35M-300.00%-12M-40.00%-21M-200.00%-12M-----500.00%-6M50.00%-3M
Income before tax -47.34%425M-214.73%-148M17.39%243M-2.55%229M-57.20%101M19.91%807M24.04%129M158.75%207M-7.48%235M0.43%236M
Income tax 517.54%238M185.00%57M154.61%83M110.00%84M-60.00%14M83.71%-57M104.52%20M-790.91%-152M233.33%40M-39.66%35M
Net income -78.36%187M-288.07%-205M-55.43%160M-25.64%145M-56.72%87M-15.54%864M-80.04%109M518.97%359M-19.42%195M13.56%201M
Net income continuous Operations -78.36%187M-288.07%-205M-55.43%160M-25.64%145M-56.72%87M-15.54%864M-80.04%109M518.97%359M-19.42%195M13.56%201M
Minority interest income
Net income attributable to the parent company -78.36%187M-288.07%-205M-55.43%160M-25.64%145M-56.72%87M-15.54%864M-80.04%109M518.97%359M-19.42%195M13.56%201M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -78.36%187M-288.07%-205M-55.43%160M-25.64%145M-56.72%87M-15.54%864M-80.04%109M518.97%359M-19.42%195M13.56%201M
Basic earnings per share -78.57%0.72-288.10%-0.79-56.12%0.61-26.32%0.56-56.41%0.34-16.21%3.36-80.37%0.42504.35%1.39-20.00%0.7611.43%0.78
Diluted earnings per share -78.38%0.72-288.10%-0.79-55.80%0.61-25.33%0.56-57.69%0.33-16.54%3.33-80.28%0.42500.00%1.38-21.05%0.7513.04%0.78
Dividend per share -69.64%0.34-92.86%0.02-92.86%0.02-92.86%0.020.00%0.280.00%1.120.00%0.280.00%0.280.00%0.280.00%0.28
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More